Alleyba says............
...........news out.CEO has done it again!!. Cut and pasted recent filing. What does it tell me ? It is obvious to me that GEM believes the stock is going much higher long term than .75 and that they believe Rapimeds will sell in BIG volume in China and domestically. They will want to exercise their warrants and this is showing us that .75 is attainable at some point unless I am misreading something.
Bob Schneiderman has engineered a deal, it appears to me which is not toxic at all. I am sure , imo, we always have option to prepay the $2,000,000 and not worry about their exercising their right to exercise the warrants. If one reads the entire filing the purpose of attaining the funds is to get Rapimeds on shelves domestically and abroad. In my opinion CEO is turning his vision into a reality. This is all on Yahoo news
Item 3.02 Unregistered Sales of Equity Securities.
In connection with entering into the financing agreement, the Registrant issued to 590 Partners Capital, LLC ("590 Partners") and GEM Global six (6) common stock purchase warrants to purchase collectively up to ten million (10,000,000) shares of the Registrant's common stock. Each of GEM Global and 590 Partners received (i) a warrant exercisable to purchase 2,000,000 shares of common stock at an exercise price of $0.41, (ii) a warrant exercisable to purchase 1,500,000 shares of common stock at an exercise price of $0.55 and (iii) a warrant exercisable to purchase 1,500,000 shares of common stock at an exercise price of $0.75. All of the warrants expire on October 10, 2018 and are only exercisable on a cash basis (they do not contain any cashless exercise provisions). Additionally, the Registrant granted registration rights to 590 Partners and GEM Global to register the resale of the shares underlying the warrants.
